Post
Sentiment towards Brexit has worsened three years after UK left EU
More than half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. …
Janssen submits NDA to FDA for PAH combination therapy
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a new drug application (NDA) for its investigational single-tablet combination …
Stealth and Pharmanovia partner for commercialisation of elamipretide
Stealth BioTherapeutics has made an exclusive licensing agreement with Pharmanovia for the commercialisation of its elamipretide to treat Barth syndrome. Pharmanovia …
Betta to commercialise C4 Therapeutics’ CFT8919 in greater China
C4 Therapeutics has entered an exclusive licensing agreement with Betta Pharmaceuticals to develop and commercialise CFT8919 across the greater China …
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will receive …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
FDA accepts Bristol Myers Squibb’s repotrectinib NDA for review
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s new drug application (NDA) for repotrectinib for priority …
University of Sydney will use AI to boost cancer drug research
The University of Sydney and Australian company Pharos Therapeutics have reached an agreement to leverage artificial intelligence (AI) to progress …
Early signals suggest oral SERD’s potential for more breast cancer patients
The Menarini Group today has announced exploratory results from its EMERALD clinical study that suggest its recently approved oral selective …
US companies drive 2023 drug launches positioned for blockbuster success by 2028
According to GlobalData's Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 …
AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery
Last week, artificial intelligence (AI) innovator AION Labs called for applications for its latest AI-powered startup. In partnership with BioMed …
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Catalent’s (Somerset, NJ, US) CEO has admitted to the company’s “disappointing” and “poor performance” over the past quarter, and dropped …
Abiogen acquires EffRx to fortify bone disease portfolio
The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals …
AstriVax received €2.5 million government grant for thermostable vaccines
AstriVax has received a €2.5 million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used …
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, …
Valneva seeks Health Canada approval for chikungunya vaccine
Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553. The vaccine is …